Platelet cyclic nucleotides (c-AMP, c-GMP) play an important role in platelet aggregation. It is reported that the elevation of c-AMP suppresses platelet aggregation by inhibition of Ca
2+ transport from the Ca
2+ storage site in the platelets. Although the role of platelet c-GMP is still obscure, it may be closely associated with platelet aggregation.
Incidence of cerebrovascular diseases (CVD) are closely related to arteriosclerosis which occurs from hypertension, diabetes mellitus and hyperlipemia etc.. Also arteriosclerosis has intimate correlation with platelet aggregability through the metabolism of arachidonic acid in platelets and arterial walls.
In this study, the platelet cyclic nucleotide levels were investigated in 28 age matched healthy controls, 31 patients with cerebral thrombosis, 18 patients with cerebral hemorrhage and 25 patients with diabetes mellitus.
The CVD stages were divided into acute and chronic stages. The acute individuals were within 10 days from the attack, while the chronic individuals were 21 days to 3 months after onset of the diseases.
Peripheral venous blood was collected into the tube containing sodium citrate (blood : sodium citrate=9 : 1) and the platelet rich plasma (PRP) was prepared by centrifugation. After adding 6% trichloroacetic acid to the PRP, it was centrifuged and the supernatant was used for the cyclic nucleotide assay. The cyclic nucleotides (c-AMP, c-GMP) were measured by radioimmunoassay.
The platelet count and the cyclic nucleotide values of the PRP were in linear correlation. Therefore, cyclic nucleotide concentration was expressed as p moles/1 × 10
8 platelets/ml.
Platelet c-AMP levels were elevated in the acute stage of cerebral hemorrhage compared with platelet c-AMP levels of the chronic stage in individuals. But there were no significant differences of platelet c-AMP levels between the acute stage of cerebral thrombosis and the chronic stage. While platelet c-AMP levels were low statistically in the chronic stage of cerebral thrombosis, cerebral hemorrhage and in diabetes mellitus compared with the healthy adult controls.
Platelet c-GMP levels were higher in the acute and in the chronic stage of cerebral thrombosis and hemorrhage compared with the age matched healthy controls. There was a tendency of an elevation of platelet c-GMP levels in the acute stage of CVD compared with platelet c-GMP levels in the chronic stage. On the other hand, there were no significant differences of platelet c-GMP levels in the diabetic patients.
c-AMP/c-GMP ratio was low in the acute and in the chronic stage of cerebral thrombosis. This ratio was also low in the chronic stage of cerebral hemorrhage, while there was no statistical difference in the ratio between diabetes mellitus and the healthy controls.
It is shown that platelet c-AMP and c-GMP levels have a close relationship to arteriosclerotic diseases (cerebral thrombosis, cerebral hemorrhage, diabetes mellitus).
View full abstract